PubRank

Cornelia C Bergmann

Author PubWeight™ 53.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J Exp Med 2002 2.38
2 Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog 2012 1.84
3 Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J Immunol 2002 1.48
4 Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J Virol 2007 1.48
5 Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J Neurosci 2012 1.46
6 Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis. J Neurosci Res 2006 1.37
7 Kinetics of virus-specific CD8+ -T-cell expansion and trafficking following central nervous system infection. J Virol 2003 1.37
8 Monocytes regulate T cell migration through the glia limitans during acute viral encephalitis. J Virol 2010 1.27
9 Efficient induction of primary and secondary T cell-dependent immune responses in vivo in the absence of functional IL-2 and IL-15 receptors. J Immunol 2003 1.23
10 Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity. J Immunol 2009 1.18
11 Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control. J Virol 2009 1.16
12 Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis. J Virol 2008 1.14
13 Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis. J Immunol 2002 1.13
14 Inhibition of interferon-gamma signaling in oligodendroglia delays coronavirus clearance without altering demyelination. Am J Pathol 2006 1.10
15 Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis. J Virol 2005 1.10
16 CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. Eur J Immunol 2006 1.10
17 RNase L mediated protection from virus induced demyelination. PLoS Pathog 2009 1.10
18 CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection. J Virol 2003 1.09
19 Distinct regulation of MHC molecule expression on astrocytes and microglia during viral encephalomyelitis. Glia 2007 1.07
20 Control of central nervous system viral persistence by neutralizing antibody. J Virol 2003 1.05
21 CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis. J Virol 2011 1.05
22 Virus-specific and bystander CD8 T cells recruited during virus-induced encephalomyelitis. J Virol 2005 1.04
23 CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis. J Virol 2011 1.03
24 Factors supporting intrathecal humoral responses following viral encephalomyelitis. J Virol 2010 1.03
25 CD4 T cells contribute to virus control and pathology following central nervous system infection with neurotropic mouse hepatitis virus. J Virol 2007 1.01
26 Mouse hepatitis virus pathogenesis in the central nervous system is independent of IL-15 and natural killer cells. Virology 2006 1.00
27 IFN-γ signaling to astrocytes protects from autoimmune mediated neurological disability. PLoS One 2012 0.97
28 Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved. Curr Opin Pharmacol 2008 0.96
29 Induction of class I antigen processing components in oligodendroglia and microglia during viral encephalomyelitis. Glia 2008 0.96
30 Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis. J Immunol 2010 0.95
31 Shifting hierarchies of interleukin-10-producing T cell populations in the central nervous system during acute and persistent viral encephalomyelitis. J Virol 2011 0.93
32 Expression of the mouse hepatitis virus receptor by central nervous system microglia. J Virol 2004 0.91
33 Differential regulation of primary and secondary CD8+ T cells in the central nervous system. J Immunol 2004 0.89
34 MMP9 deficiency does not decrease blood-brain barrier disruption, but increases astrocyte MMP3 expression during viral encephalomyelitis. Glia 2011 0.88
35 Ifit2 deficiency results in uncontrolled neurotropic coronavirus replication and enhanced encephalitis via impaired alpha/beta interferon induction in macrophages. J Virol 2013 0.88
36 Expression of a dominant negative IFN-gammareceptor on mouse oligodendrocytes. Glia 2005 0.88
37 Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis. J Virol 2013 0.87
38 Oligodendroglia are limited in type I interferon induction and responsiveness in vivo. Glia 2012 0.86
39 Enhanced CD8 T-cell anti-viral function and clinical disease in B7-H1-deficient mice requires CD4 T cells during encephalomyelitis. J Neuroinflammation 2012 0.85
40 Astrocyte expression of a dominant-negative interferon-gamma receptor. J Neurosci Res 2005 0.84
41 IFN-γ protects from lethal IL-17 mediated viral encephalomyelitis independent of neutrophils. J Neuroinflammation 2012 0.84
42 Gamma interferon signaling in oligodendrocytes is critical for protection from neurotropic coronavirus infection. J Virol 2009 0.83
43 IL-15-independent antiviral function of primary and memory CD8+ T cells. Virology 2005 0.82
44 Vaccine-induced memory CD8+ T cells cannot prevent central nervous system virus reactivation. J Immunol 2006 0.82
45 Role of CD25(+) CD4(+) T cells in acute and persistent coronavirus infection of the central nervous system. Virology 2013 0.81
46 IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis. J Neuroimmunol 2013 0.81
47 Altered neuroantigen-specific cytokine secretion in a Th2 environment reduces experimental autoimmune encephalomyelitis. J Neuroimmunol 2006 0.80
48 Intrathecal humoral immunity to encephalitic RNA viruses. Viruses 2013 0.80
49 IL-15 independent maintenance of virus-specific CD8(+) T cells in the CNS during chronic infection. J Neuroimmunol 2008 0.80
50 Glia expression of MHC during CNS infection by neurotropic coronavirus. Adv Exp Med Biol 2006 0.77
51 The art of survival during viral persistence. J Neurovirol 2002 0.75